fashion -WSS

fashion

author：knowledge 2025-08-23 06:46:06 - browse：78297

A person wears a headset projecting a brain -- health tech coverage from STAT — Adobe

Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the neurodegenerative disease.

With the new Series B extension funding, the Cambridge, Mass.-based company has now raised $128 million to develop its headset that uses gamma frequency light and sound stimulation to combat the cognitive decline that’s the hallmark of Alzheimer’s. Cognito is currently undertaking a large study of the treatment and CEO Brent Vaughan told STAT he expects the company to complete the trial and submit data to the Food and Drug Administration for review by the end of 2025.

While under treatment, patients use the device for one hour per day in their homes. The light and sound is supposed to stimulate brain activity that’s disrupted by neurodegenerative conditions, potentially helping to preserve brain structure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

WSS

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Solving academic medical centers' existential crisis

Do digital therapeutics have a future in medicine?

General Catalyst, Summa Health deal will turn on physician buy

hotspot

fashion

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

NVIDIA and Google execs on the future of AI and drug discovery

Hollywood unions extend contract negotiations for actors

When prostate cancer spreads, where it goes matters

Guidelines to prevent youth baseball injuries need more muscle

Do digital therapeutics have a future in medicine?

Sports medicine is finally prioritizing gender equality

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Anesthesiologist group: stop taking Ozempic before surgery

Woodcock on FDA’s accelerated approval and her next chapter

entertainment

ARCH Venture Partners is raising $3 billion for a life sciences fund

Apple Vision Pro: A first look at health apps on the new VR headset

General Catalyst, Summa Health deal will turn on physician buy

Wearables generate powerful data but its not useful to doctors, yet

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Bird flu: Don't repeat Covid's 'health versus the economy' framing

explore

explore

entertainment

focus